Results 101 to 110 of about 61,850 (209)

Acute malaria dysregulates specialized lymph node macrophages to suppress vaccine-elicited protection against the Ebola virus

open access: yesmBio
The filovirus, Ebola virus (EBOV), causes outbreaks of EBOV disease (EVD) throughout equatorial Africa. ERVEBO is a replication-competent recombinant vesicular stomatitis virus-vectored vaccine encoding the EBOV glycoprotein (recombinant vesicular ...
Jonah Elliff   +12 more
doaj   +1 more source

Interferon Response and Viral Evasion by Members of the Family Rhabdoviridae

open access: yesViruses, 2009
Like many animal viruses, those of the Rhabdoviridae family, are able to antagonize the type I interferon response and cause disease in mammalian hosts. Though these negative-stranded RNA viruses are very simple and code for as few as five proteins, they
Matthias J. Schnell   +2 more
doaj   +1 more source

Single-cycle viral gene expression, rather than progressive replication and oncolysis, is required for VSV therapy of B16 melanoma [PDF]

open access: yes, 2010
A fully intact immune system would be expected to hinder the efficacy of oncolytic virotherapy by inhibiting viral replication. Simultaneously, however, it may also enhance antitumor therapy through initiation of proinflammatory, antiviral cytokine ...
Barber, G   +7 more
core   +1 more source

Vesicular Stomatitis Virus Transmission: A Comparison of Incriminated Vectors

open access: yesInsects, 2018
Vesicular stomatitis (VS) is a viral disease of veterinary importance, enzootic in tropical and subtropical regions of the Americas. In the U.S., VS produces devastating economic losses, particularly in the southwestern states where the outbreaks display
Paula Rozo-Lopez   +2 more
doaj   +1 more source

Dose-dependent T-cell Dynamics and Cytokine Cascade Following rVSV-ZEBOV Immunization. [PDF]

open access: yes, 2017
BACKGROUND: The recent West African Ebola epidemic led to accelerated efforts to test Ebola vaccine candidates. As part of the World Health Organisation-led VSV Ebola Consortium (VEBCON), we performed a phase I clinical trial investigating rVSV-ZEBOV (a ...
Addo, MM   +22 more
core   +1 more source

Vesicular stomatitis virus [PDF]

open access: yesCancer Cell, 2003
Giedlin, Martin A   +2 more
openaire   +1 more source

Cellular microRNAs Repress Vesicular Stomatitis Virus but Not Theiler’s Virus Replication

open access: yesViruses, 2016
Picornavirus’ genomic RNA is a positive-stranded RNA sequence that also serves as a template for translation and replication. Cellular microRNAs were reported to interfere to different extents with the replication of specific picornaviruses, mostly ...
Aurélie De Cock, Thomas Michiels
doaj   +1 more source

MORPHOLOGY OF VESICULAR STOMATITIS VIRUS [PDF]

open access: yesJournal of Bacteriology, 1954
T L, CHOW, F H, CHOW, R P, HANSON
openaire   +2 more sources

A system for production of defective interfering particles in the absence of infectious influenza A virus

open access: yes, 2019
Influenza A virus (IAV) infection poses a serious health threat and novel antiviral strategies are needed. Defective interfering particles (DIPs) can be generated in IAV infected cells due to errors of the viral polymerase and may suppress spread of wild
Arora, P.   +6 more
core   +2 more sources

Inactivation of Vesicular Stomatitis Virus by Disinfectants

open access: yesApplied Microbiology, 1970
Twenty-four chemical disinfectants considered to be viricidal were tested. Ten disinfectants were not viricidal for vesicular stomatitis virus within 10 min at 20 C when an LD 50 titer of 10 8.5 virus units per 0.1 ml were to be inactivated.
openaire   +2 more sources

Home - About - Disclaimer - Privacy